| A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome P Soret, C Le Dantec, E Desvaux, N Foulquier, B Chassagnol, S Hubert, ... Nature communications 12 (1), 3523, 2021 | 106 | 2021 |
| Toll-like receptors, infections, and rheumatoid arthritis MI Arleevskaya, RV Larionova, WH Brooks, E Bettacchioli, ... Clinical reviews in allergy & immunology 58, 172-181, 2020 | 95 | 2020 |
| Complement system: a neglected pathway in immunotherapy A Bordron, C Bagacean, A Tempescul, C Berthou, E Bettacchioli, S Hillion, ... Clinical reviews in allergy & immunology 58, 155-171, 2020 | 39 | 2020 |
| An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases E Bettacchioli, C Le Gaffric, M Mazeas, MO Borghi, J Frostegard, ... Journal of Translational Autoimmunity 4, 100090, 2021 | 18 | 2021 |
| Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases A Marziale, E Bettacchioli, G Picart, S Nafai, H Galinat, PL Meroni, ... Journal of Autoimmunity 115, 102524, 2020 | 15 | 2020 |
| Machine learning for the identification of a common signature for anti–SSA/Ro 60 antibody expression across autoimmune diseases N Foulquier, C Le Dantec, E Bettacchioli, C Jamin, ME Alarcón‐Riquelme, ... Arthritis & Rheumatology 74 (10), 1706-1719, 2022 | 12 | 2022 |
| News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination E Bettacchioli, S Nafai, Y Renaudineau Clinical immunology 205, 106-115, 2019 | 11 | 2019 |
| Harnessing large language models (LLMs) for candidate gene prioritization and selection M Toufiq, D Rinchai, E Bettacchioli, BSA Kabeer, T Khan, B Subba, ... Journal of Translational Medicine 21 (1), 728, 2023 | 9 | 2023 |
| Is hypophosphataemia an independent predictor of mortality in critically ill patients with bloodstream infection? A multicenter retrospective cohort study M Padelli, C Aubron, O Huet, G Héry-Arnaud, V Vermeersch, C Hoffmann, ... Australian Critical Care 34 (1), 47-54, 2021 | 9 | 2021 |
| Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies N Salma, L Julie, B Boutahar, B Eleonore, P Elisabeth, JJ Sandrine, ... Clinical Immunology 194, 92-99, 2018 | 9 | 2018 |
| Association of combined anti-ro52/TRIM21 and anti-ro60/SSA antibodies with increased sjögren disease severity through interferon pathway activation E Bettacchioli, A Saraux, A Tison, D Cornec, M Dueymes, N Foulquier, ... Arthritis & Rheumatology 76 (5), 751-762, 2024 | 6* | 2024 |
| Tocilizumab controls bone turnover in early polymyalgia rheumatica GC Alegria, F Garrigues, E Bettacchioli, D Loeuille, A Saraux, D Cornec, ... Joint Bone Spine 88 (3), 105117, 2021 | 5 | 2021 |
| Identifying clinical, biological, and quality of life variables associated with depression, anxiety, and fatigue in pSS and sicca syndrome patients: a prospective single-centre … L Miglianico, D Cornec, V Devauchelle-Pensec, S Berrouiguet, M Walter, ... Joint bone spine 89 (6), 105413, 2022 | 3 | 2022 |
| Dual MPO/PR3 ANCA positivity and vasculitis: insights from a 7-cases study and an AI-powered literature review E Bettacchioli, JB Foulquier, B Chevet, ECL Gall, C Hanrotel, L Lanfranco, ... Rheumatology, keae170, 2024 | | 2024 |
| Enhancing Sjögren's Disease Diagnosis through The Convergence of Multiparametric Approaches and Big Data Intelligence. E Bettacchioli, A Saraux, N Foulquier, D Cornec, V Devauchelle-Pensec Arthritis & Rheumatology (Hoboken, NJ), 2024 | | 2024 |
| BiomiX, a User-Friendly Bioinformatic Tool for Automatized Multiomics Data Analysis and Integration C Iperi, A Fernandez-Ochoa, G Barturen, JO Pers, N Foulquier, ... bioRxiv, 2024.06. 14.599059, 2024 | | 2024 |
| An interactive web application for exploring systemic lupus erythematosus blood transcriptomic diversity E Bettacchioli, L Chiche, D Chaussabel, D Cornec, N Jourde-Chiche, ... Database 2024, baae045, 2024 | | 2024 |
| Les anticorps anti-Ro52 pourraient être associés à une plus grande sévérité de la maladie chez les patients atteints de la maladie de Sjögren par l’activation de la voie de l … E Bettacchioli, A Saraux, A Tison, D Cornec, M Dueymes, N Foulquier, ... Revue du Rhumatisme 90, A210, 2023 | | 2023 |
| OP0217 ANTI-RO52 ANTIBODIES ARE ASSOCIATED WITH HIGHER DISEASE SEVERITY IN PATIENTS WITH SJÖGREN DISEASE THROUGH ACTIVATION OF THE INTERFERON PATHWAY E Bettacchioli, A Saraux, A Tison, D Cornec, M Dueymes, N Foulquier, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 142-142, 2023 | | 2023 |
| What Does Isolated Anti-Ro52 Antibody Positivity Mean in Sjogren's Syndrome? E Bettacchioli, A Saraux, A Tison, D Cornec, M Dueymes, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 40 (12), 35-36, 2022 | | 2022 |
